Compare AUTL & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | ACIC |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 540.4M |
| IPO Year | 2025 | 2007 |
| Metric | AUTL | ACIC |
|---|---|---|
| Price | $1.94 | $9.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 216.9K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.33% |
| EPS Growth | N/A | ★ 39.61 |
| EPS | N/A | ★ 0.83 |
| Revenue | $10,120,000.00 | ★ $335,439,000.00 |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | $1.00 |
| P/E Ratio | ★ N/A | $11.05 |
| Revenue Growth | ★ 496.00 | 13.07 |
| 52 Week Low | $1.18 | $9.06 |
| 52 Week High | $2.58 | $13.06 |
| Indicator | AUTL | ACIC |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 38.03 |
| Support Level | $1.37 | $9.10 |
| Resistance Level | $1.92 | $9.68 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 13.76 | 30.28 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.